Australian researchers report on findings from a functional analysis of cancer drug resistance genes in cell lines and tumor xenograft models in mice. Using a CRISPR-Cas9 gene editing-based knockout screening in cancer cells, the team tallied the genes and pathways targeted by cancer treatments, while unearthing 10 genes related to resistance to multiple drugs.